Related Experiment Video
Updated: Jan 7, 2026

A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration
Published on: January 22, 2016
Breaking the Bowel: A Subacute Ischemic Complication of Chronic Methamphetamine Use
Benjamin Moran1, Tiffany Scotto2, Sophia Sheikh1
1Emergency Medicine, University of Florida College of Medicine - Jacksonville, Jacksonville, USA.
None:
Methamphetamine is a potent sympathomimetic agent primarily associated with cardiovascular and neuropsychiatric effects. However, its gastrointestinal complications, particularly ischemic bowel disease, are under-recognized in emergency medicine literature. A 34-year-old man with a history of chronic methamphetamine use presented to the emergency department (ED) seeking medical clearance for rehabilitation admission. He also reported mild, diffuse abdominal pain persisting for three days. Vital signs revealed tachycardia and hypotension. Physical examination showed mild subjective diffuse abdominal tenderness without peritoneal signs. Laboratory studies indicated leukocytosis, elevated lactate, and acute kidney injury. Non-contrast abdominal and pelvic computed tomography (CT) demonstrated pneumoperitoneum and extensive mesenteric stranding consistent with ischemia. The patient was managed with intravenous fluids, broad-spectrum antibiotics, and emergent surgical consultation. Exploratory laparotomy revealed hemoperitoneum, a large abscess cavity, necrosis of the cecum, and mesenteric ischemia. A resection of the cecum and terminal ileum was performed. Postoperatively, the patient required intensive care management for septic shock and renal failure but eventually recovered and was discharged after 15 days. This case underscores the importance of considering chronic methamphetamine use as a potential etiology for gastrointestinal ischemia and sepsis, even in patients presenting with subtle abdominal complaints. Early recognition and intervention are crucial for improving outcomes in this high-risk population.
Related Concept Videos
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
Assessment of the Rectum and Anus
Rectal Inspection
Begin by inspecting the perianal and anal areas for color, texture, rashes,...
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids

